RxDoctor Payments Data

Spencer Melby, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Orem, UTNPI 1720081243

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $20,951 of the $29,644 with a category attached, or 70.7%. Clearflow Inc. accounts for 87.3% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2020 at $15,411 and has fallen 98.4% since, to $251 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$29,644in general payments, 2019–2025

Across 49 payments — averaging $604.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Clearflow Inc.$26K
  • Livanova USA, Inc.$1K
  • Edwards Lifesciences$755
  • Artivion, Inc.$449
  • Medtronic$234
  • Johnson & Johnson$206
  • plus $766 from 14 others
$402,634in research payments, 2019–2025

Across 62 payments — averaging $6494.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$255K
  • Edwards Lifesciences$93K
  • Quest Medical Inc.$42K
  • Livanova USA, Inc.$13K

What the payments were for

  • Consulting fees$6,00020%
  • Speaking & faculty fees$20,95171%
  • Travel & lodging$280%
  • Food & beverage$2,6659%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,644 in reported general payments places this provider in the 95th percentile of 46 thoracic surgery (cardiothoracic vascular surgery) providers in Utah.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Utah

Medicare billing

Part B allowed, 2024
$21,693
Medicare patients
11
Services billed
37

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Orem

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →